Results 251 to 260 of about 24,793 (292)
Some of the next articles are maybe not open access.

Degradation of Chlorambucil in Aqueous Solution

Journal of Pharmaceutical Sciences, 1980
The stability of chlorambucil and its degradation product 4-[p-(2-chloroethyl-2-hydroxyethylamino)phenyl]butyric acid (I) was studied using reversed-phase high-pressure liquid chromatography. The degradation rate of chlorambucil was unaffected by pH between pH 5 and 10 but decreased at lower pH. The degradation rates of chlorambucil and I differed only
Staffan Eksborg   +3 more
openaire   +3 more sources

Cutaneous Reaction to Chlorambucil

Archives of Dermatology, 1977
To the Editor.— Chlorambucil is an oral alkylating agent that has been used since early 1950, particularly for the treatment of chronic lymphatic leukemia. The side effects are gastrointestinal symptoms, such as nausea and vomiting, and bone marrow depression. Allergic skin reactions are extremely rare.
S. M. Rajah, L. G. Millard
openaire   +2 more sources

Squaric Acid-Coumarin-Chlorambucil: Photoresponsive Single-Component Fluorescent Organic Nanoconjugates for Self-Monitored Therapeutics

ACS Applied Nano Materials, 2018
In this paper, we have developed photoresponsive fluorescent organic nanoconjugates based on a single-component system for effective cancer treatment by a synergistic combination of photodynamic therapy (PDT) and chemotherapy. Our single-component system
A. Chaudhuri   +6 more
semanticscholar   +1 more source

Chlorambucil and Acute Intermittent Porphyria

Clinical Oncology, 2002
A 54-year-old women with quiescent acute intermittent porphyria (AIP) developed low-grade non-Hodgkin's lymphoma. She was successfully treated with chlorambucil without any significant rise in urinary proto-porphyrins. The case is described and a review of chemotherapy use in AIP is presented.
S.J. Whitaker, J.H. Davies
openaire   +2 more sources

THE ONCOGENICITY OF CHLORAMBUCIL IN RHEUMATOID ARTHRITIS

Rheumatology, 1988
Chlorambucil is useful in patients with rheumatoid arthritis (RA) refractory to other agents but there is concern about the risk of haematological malignancy with this agent. A retrospective survey was performed to assess the incidence of all types of malignancy in 39 patients treated with chlorambucil (mean daily dose 4.25 mg, mean duration of ...
Milton Cohen   +6 more
openaire   +3 more sources

The pharmacokinetics of prednimustine and chlorambucil in the rat

Cancer Chemotherapy and Pharmacology, 1981
In the rat prednimustine, the prednisolone ester of chlorambucil, is much less toxic than equimolar doses of chlorambucil, when administered subcutaneously (SC). This is due to differences in alkylating agent pharmacokinetics. Prednimustine injected SC produced low plasma concentrations (less than 5 microM) of the alkylating metabolites chlorambucil ...
D. R. Newell   +2 more
openaire   +3 more sources

A p-Hydroxyphenacyl-Benzothiazole-Chlorambucil Conjugate as a Real-Time-Monitoring Drug-Delivery System Assisted by Excited-State Intramolecular Proton Transfer.

Angewandte Chemie, 2016
Among the well-known phototriggers, the p-hydroxyphenacyl (pHP) group has consistently enabled the very fast, efficient, and high-conversion release of active molecules.
Shrabani Barman   +7 more
semanticscholar   +1 more source

Chlorambucil inhibition by dimethyl sulfoxide and thiosulfate: Implications for chlorambucil chemotherapy

Medical Hypotheses, 1980
Chlorambucil alkylation of pyridine, a model for nucleotides, appears to be first order in chlorambucil, but zero order in pyridine, and is strongly inhibited by dimethylsulfoxide. The same results are seen with chlorambucilyl [3H]prolyl proline; full alkylation activity was regained upon removal of dimethylsulfoxide.
openaire   +3 more sources

A Binding Site for Chlorambucil on Metallothionein

Biochemistry, 1996
It is of interest to test the hypothesis that induced metallothionein (MT) acts in acquired drug resistance by covalent sequestration. In this study MT was incubated in vitro with chlorambucil (CHB) under conditions where only 1:1 covalent adducts were formed.
Joseph Zaia   +6 more
openaire   +3 more sources

Treatment of Behcet's Disease With Chlorambucil

Archives of Ophthalmology, 1970
Eleven patients with Behcet's (and neuro-Behcet's) disease in the active and progressive stages were treated with chlorambucil (Leukeran). Follow-up varied between three weeks and 17 months. Results were favorable in all, and the drug was superior to other forms of treatment in that there was arrest and some amelioration of the disease.
Jubran G. Mamo, Samir A. Azzam
openaire   +3 more sources

Home - About - Disclaimer - Privacy